GEBCX
Price
$11.81
Change
+$0.04 (+0.34%)
Updated
Sep 12 closing price
Net Assets
25.16M
VEMIX
Price
$33.75
Change
+$0.08 (+0.24%)
Updated
Sep 12 closing price
Net Assets
130.49B
Interact to see
Advertisement

GEBCX vs VEMIX

Header iconGEBCX vs VEMIX Comparison
Open Charts GEBCX vs VEMIXBanner chart's image
Goldman Sachs ESG Em Mkts Eq C
Price$11.81
Change+$0.04 (+0.34%)
VolumeN/A
Net Assets25.16M
Vanguard Emerging Mkts Stock Idx Instl
Price$33.75
Change+$0.08 (+0.24%)
VolumeN/A
Net Assets130.49B
GEBCX vs VEMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GEBCX vs. VEMIX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEBCX is a Buy and VEMIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 130B vs. GEBCX (25.2M). VEMIX pays higher dividends than GEBCX: VEMIX (2.68) vs GEBCX (0.05). GEBCX was incepted earlier than VEMIX: GEBCX (7 years) vs VEMIX (25 years). GEBCX (3.85) is less costly to investors than VEMIX (0.09). GEBCX is a more actively managed with annual turnover of: 34.00 vs. VEMIX (8.00). GEBCX has a lower initial minimum investment than VEMIX: GEBCX (1000) vs VEMIX (5000000). VEMIX annual gain was more profitable for investors over the last year : 22.98 vs. GEBCX (20.57). VEMIX return over 5 years is better than : 35.27 vs. GEBCX (6.22).
GEBCXVEMIXGEBCX / VEMIX
Total Expense Ratio2.120.092,356%
Annual Report Gross Expense Ratio3.850.094,278%
Fund Existence7 years25 years-
Gain YTD22.63821.009108%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets25.2M130B0%
Annual Yield % from dividends0.052.682%
Returns for 1 year20.5722.9890%
Returns for 3 years33.8841.3882%
Returns for 5 years6.2235.2718%
Returns for 10 yearsN/A83.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR48.681.48
+3.14%
Nektar Therapeutics
MCY79.360.33
+0.42%
Mercury General Corp
CRIS1.82N/A
N/A
Curis
AMP497.08-3.89
-0.78%
Ameriprise Financial
CXDO6.77-0.08
-1.17%
Crexendo